ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
G1 Therapeutics and Genor Biopharma sign agreement for Lerociclib
June 24, 2020As per the exclusive license agreement, Genor to lead clinical development, regulatory submissions and commercialisation of lerociclib in Asia-Pacific. -
Quantum Leap Healthcare, G1 Therapeutics Announce Trilaciclib Evaluation
January 16, 2020Quantum Leap Healthcare Collaborative™ and G1 Therapeutics announced a collaboration to evaluate trilaciclib, an investigational therapy designed to improve outcomes for people with cancer treated with chemotherapy, in a new randomized ... -
G1 Therapeutics Expands Executive Leadership Team with Appointment of John Demaree as Chief Commercial Officer and Stillman Hanson as General Counsel
July 10, 2018G1 Therapeutics, Inc. (Nasdaq:GTHX), a clinical-stage oncology company, today announced appointments for two newly created executive leadership roles to support the company’s continued growth. John Demaree joins the company as Chief Commercial Officer and -
G1 Therapeutics Unveils Positive Mid-Stage Data for Myelopreservation in SCLC Patients
March 06, 2018A mid-stage program aimed at treating myelosuppression in lung cancer patients undergoing chemotherapy is yielding positive results
Pharma Sources Insight January 2025
